Does the Virginia state employee health plan cover Zepbound or Wegovy?
Last updated
Covered with prior authorization; new users need a BMI of 35 or more since July 1, 2026.
If it is not covered: the lowest cash prices now

Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
Covered with prior authorization; new users need a BMI of 35 or more since July 1, 2026. New requests for weight-loss GLP-1 therapy from July 1, 2026 must meet new prior authorization criteria. In its words: "Any initial authorization request for GLP 1 therapy for weight loss submitted on or after July 1, 2026 must meet the new PA criteria" (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026). Members already approved who stay compliant are not held to the new BMI 35 rule when their approval renews. In its words: "Members who are currently using GLP 1 weight loss medications under an active PA, and remain continuously compliant, will not be required to meet the new BMI ≥ 35 criteria when their PA renews." (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026).
the Virginia state employee health plan, Zepbound and Wegovy: common questions
Does the Virginia state employee health plan cover Zepbound for weight loss?
Covered with prior authorization; new users need a BMI of 35 or more since July 1, 2026. New requests for weight-loss GLP-1 therapy from July 1, 2026 must meet new prior authorization criteria. In its words: "Any initial authorization request for GLP 1 therapy for weight loss submitted on or after July 1, 2026 must meet the new PA criteria" (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026). Members already approved who stay compliant are not held to the new BMI 35 rule when their approval renews. In its words: "Members who are currently using GLP 1 weight loss medications under an active PA, and remain continuously compliant, will not be required to meet the new BMI ≥ 35 criteria when their PA renews." (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026). Zepbound not covered: the cash price at your dose
Does the Virginia state employee health plan cover Wegovy for weight loss?
Covered with prior authorization; new users need a BMI of 35 or more since July 1, 2026. New requests for weight-loss GLP-1 therapy from July 1, 2026 must meet new prior authorization criteria. In its words: "Any initial authorization request for GLP 1 therapy for weight loss submitted on or after July 1, 2026 must meet the new PA criteria" (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026). Members already approved who stay compliant are not held to the new BMI 35 rule when their approval renews. In its words: "Members who are currently using GLP 1 weight loss medications under an active PA, and remain continuously compliant, will not be required to meet the new BMI ≥ 35 criteria when their PA renews." (Virginia Department of Human Resource Management, Health Benefits E-News, August 12, 2026, content.govdelivery.com/accounts/VADHRM/bulletins/424742e, read Nov 19, 2026). Wegovy not covered: the cash price at your dose
What do Zepbound and Wegovy cost if the Virginia state employee health plan does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Virginia; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Virginia. Every GLP-1's cash price without insurance
Does Medicaid cover Zepbound or Wegovy?
It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.